Atria Wealth Solutions Inc. cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 58.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 55,657 shares of the company’s stock after selling 78,669 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Procter & Gamble were worth $8,880,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Stableford Capital II LLC boosted its position in Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock worth $993,000 after acquiring an additional 61 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management boosted its position in Procter & Gamble by 2.3% during the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock worth $476,000 after acquiring an additional 63 shares during the last quarter. Private Management Group Inc. raised its stake in Procter & Gamble by 4.8% during the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after purchasing an additional 64 shares during the period. Lantz Financial LLC raised its stake in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after purchasing an additional 64 shares during the period. Finally, Orca Investment Management LLC raised its stake in Procter & Gamble by 2.0% during the second quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock worth $516,000 after purchasing an additional 64 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 over the last ninety days. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the previous year, the firm earned $1.40 EPS. The business’s revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Analyst Ratings Changes
A number of equities analysts have commented on PG shares. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $172.21.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- What Are Dividend Challengers?
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What is a Special Dividend?
- Datavault: A Speculative AI Play, But Beware of Volatility
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.